Literature DB >> 22475897

FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.

Masatoyo Nakajo1, Masayuki Nakajo, Yoriko Kajiya, Atsushi Tani, Takuro Kamiyama, Ryuji Yonekura, Yoshihiko Fukukura, Tsutomu Matsuzaki, Kengo Nishimoto, Mitsuharu Nomoto, Chihaya Koriyama.   

Abstract

PURPOSE: To compare primary tumor (18)F-fluorodeoxyglucose (FDG) maximum standardized uptake value (SUV(max)) and diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) obtained in the same patients with head and neck squamous cell carcinoma (HNSCC) to clarify the prognostic significance of both indexes.
MATERIALS AND METHODS: The study population comprised 26 patients with HNSCC visible on both pretreatment FDG PET/CT and DWI. Correlation between SUV(max) and ADC (b values; 0 and 800 seconds/mm(2)) was analyzed by the Spearman's rank test. Disease-free survival (DFS) was calculated by the Kaplan-Meier method. Prognostic significance was assessed by the long-rank test and Cox proportional hazards analysis.
RESULTS: SUV(max) and ADC correlated significantly and negatively (ρ = -0.566, P = 0.005). High (>12.1) SUV(max) (P < 0.001), low (≤ 0.88) ADC (P = 0.009), high (T3-4) T stage (P = 0.030), and high (N2-3) N stage (P = 0.007) were significant in predicting poor 2-year DFS. The accuracy for predicting disease events was 81% (21/26) for SUV(max) (>12.1) and 73% (19/26) for ADC(≤ 0.88) without significant difference between them (P = 0.52). Disease event hazards ratios for significant unadjusted SUV(max) (P = 0.015) and ADC (P = 0.039) remained significant when adjusted for other dichotomized clinical covariates (SUV(max); P = 0.009-0.039, ADC; P = 0.017-0.037) except SUV(max) for ADC and ADC for SUV(max) and T stage.
CONCLUSION: These results suggest that pretreatment primary tumor SUV(max) and ADC correlate significantly and negatively and both may have similar potential to predict DFS or disease events of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475897     DOI: 10.1097/RLU.0b013e318248524a

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  36 in total

1.  Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy.

Authors:  Kimiteru Ito; Keigo Shimoji; Yoko Miyata; Kouhei Kamiya; Ryogo Minamimoto; Kazuo Kubota; Momoko Okasaki; Miyako Morooka; Jyunkichi Yokoyama
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

2.  Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.

Authors:  Shu-Hang Ng; Chun-Ta Liao; Chien-Yu Lin; Sheng-Chieh Chan; Yu-Chun Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Lan-Yan Yang; Jiun-Jie Wang
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

Review 3.  The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.

Authors:  Kee H Wong; Rafal Panek; Shreerang A Bhide; Christopher M Nutting; Kevin J Harrington; Katie L Newbold
Journal:  Br J Radiol       Date:  2017-03       Impact factor: 3.039

Review 4.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

5.  Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation.

Authors:  Marcelo A Queiroz; Martin Hüllner; Felix Kuhn; Gerhardt Huber; Christian Meerwein; Spyros Kollias; Gustav von Schulthess; Patrick Veit-Haibach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-05       Impact factor: 9.236

Review 6.  [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].

Authors:  P Stumpp; S Purz; O Sabri; T Kahn
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

7.  Meta-analysis of diffusion-weighted imaging for predicting locoregional failure of chemoradiotherapy in patients with head and neck squamous cell carcinoma.

Authors:  Qiming Zhou; Fangfang Zeng; Yao Ding; Clifton D Fuller; Jihong Wang
Journal:  Mol Clin Oncol       Date:  2017-11-15

8.  Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters.

Authors:  Zhaowei Meng; Guizhi Zhang; Haoran Sun; Jian Tan; Chunshun Yu; Weijun Tian; Weidong Li; Zhiqiang Yang; Mei Zhu; Qing He; Yujie Zhang; Shugao Han
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

9.  Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.

Authors:  Lorenzo Preda; Giorgio Conte; Luke Bonello; Caterina Giannitto; Laura L Travaini; Sara Raimondi; Paul E Summers; Ansarin Mohssen; Daniela Alterio; Maria Cossu Rocca; Chiara Grana; Francesca Ruju; Massimo Bellomi
Journal:  Eur Radiol       Date:  2016-03-10       Impact factor: 5.315

10.  Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.

Authors:  M Ravanelli; A Grammatica; M Maddalo; M Ramanzin; G M Agazzi; E Tononcelli; S Battocchio; P Bossi; M Vezzoli; R Maroldi; D Farina
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.